文献速递骨质疏松与代谢性骨病

慢性肾脏病与髋部低骨密度相关,但与脊柱低骨密度无关

Chronic kidney disease is associated with low BMD at the hip but not at the spine.
PubMed 文献 · Osteoporos Int · 2019-01-28

该研究纳入1172例各类肾脏疾病患者,分析2008年1月1日至2017年12月31日的双能X线吸收测定法(DXA)数据。结果显示,随着慢性肾脏病(CKD)进展,骨量正常者比例下降,骨量减少和骨质疏松比例增加,主要归因于全髋部位受累;以估算肾小球滤过率(eGFR)>90 ml/min为参照,eGFR 30-60和15-30 ml/min/1.73 m2的患者髋部骨质疏松/骨量减少的比值比分别为1.51(95%CI 1.01-2.24)和1.91(95%CI 1.13-3.20),而CKD分期与脊柱骨质疏松/骨量减少风险无显著关联。

要点

  • 随着CKD进展,骨量正常者比例下降,骨量减少和骨质疏松比例增加,主要因全髋受累。
  • eGFR 30-60和15-30 ml/min/1.73 m2患者髋部骨质疏松/骨量减少的OR分别为1.51和1.91。
  • 无CKD分期与脊柱骨质疏松/骨量减少风险显著相关。

核心结论

  • CKD患者低骨密度与年龄和甲状旁腺功能亢进相关,且主要影响髋部。

研究设计与样本

  • 研究纳入1172例各类肾脏疾病患者,81.3%为女性,79.9%为白人,8.1%患糖尿病,分析2008年1月1日至2017年12月31日的DXA、临床、人口学和生化数据。

主要发现

  • 至少一个部位(全髋或脊柱)骨量减少和骨质疏松的发生率分别为32.7%和20.0%。
  • 随着CKD进展,骨量正常者比例下降,骨量减少和骨质疏松比例增加,主要归因于全髋受累,尤其在eGFR<60 ml/min/1.73 m2的患者中。
  • 较老年龄和甲状旁腺功能亢进是全髋骨质疏松/骨量减少的独立危险因素;女性、较老年龄和较高的iCa与脊柱骨质疏松/骨量减少风险独立相关。
  • 以eGFR>90 ml/min为参照,eGFR 30-60和15-30 ml/min/1.73 m2患者髋部骨质疏松/骨量减少的OR分别为1.51(95%CI 1.01-2.24)和1.91(95%CI 1.13-3.20)。
  • 无CKD分期与脊柱骨质疏松/骨量减少风险显著相关。

关键数值与推荐

  • 髋部骨质疏松/骨量减少的OR:eGFR 30-60 ml/min/1.73 m2组1.51(95%CI 1.01-2.24),eGFR 15-30 ml/min/1.73 m2组1.91(95%CI 1.13-3.20),参照组eGFR>90 ml/min。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Although chronic kidney disease is associated with other bone disorders, osteoporosis can be found in this context, and it is defined based on bone mineral density (BMD), measured by dual-energy X-ray absorptiometry. As CKD progresses, the percentage of normal BMD decreases, whereas that of osteopenia/osteoporosis increases, mostly due to hip involvement, particularly in patients with reduced renal function. INTRODUCTION: Osteoporosis is a highly prevalent disease in patients with chronic kidney disease (CKD). We investigated the features of bone mineral density (BMD) in patients with assorted kidney diseases and hypothesized that low BMD, as measured by dual-energy X-ray absorptiometry (DXA), would be more prevalent as kidney function decreased and would correlate with biomarkers of mineral and bone disease. METHODS: DXA obtained from January 1, 2008, to December 31, 2017, clinical, demographic, and biochemical data at the time of image acquisition were recorded. Data from 1172 patients were included in this study (81.3% women, 79.9% white, and 8.1% diabetic). RESULTS: Osteopenia and osteoporosis in at least one site (total hip or spine) were found in 32.7% and 20.0% of patients, respectively. As CKD progressed, the percentage of patients with normal BMD decreased, whereas the percentage of osteopenia and osteoporosis increased, which was mostly due to the total hip involvement, particularly in patients with estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2. Older age and hyperparathyroidism were independent risk factors for osteopenia/osteoporosis at the total hip; female gender, older age, and higher iCa were independently associated with the risk of osteopenia/osteoporosis at the spine. With eGFR > 90 ml/min as reference, the odds ratios for osteoporosis/osteopenia at the hip were 1.51 (95% CI 1.01-2.24) and 1.91 (95% CI 1.13-3.20) for patients with eGFR 30-60 and 15-30 ml/min/1.73 m2, respectively. No CKD stage was significantly associated with the risk of osteoporosis/osteopenia at the spine. CONCLUSION: Our results highlighted that low BMD in patients with CKD is associated with age and hyperparathyroidism, and affects predominantly the hip.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Bezerra de Carvalho KS, Vasco RFV, Custodio MR, et al. Chronic kidney disease is associated with low BMD at the hip but not at the spine. Osteoporos Int. 2019. PMID: 30693381. doi:10.1007/s00198-019-04864-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。